246 related articles for article (PubMed ID: 28364121)
1. Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis.
Yu-Wai-Man C; Spencer-Dene B; Lee RMH; Hutchings K; Lisabeth EM; Treisman R; Bailly M; Larsen SD; Neubig RR; Khaw PT
Sci Rep; 2017 Mar; 7(1):518. PubMed ID: 28364121
[TBL] [Abstract][Full Text] [Related]
2. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.
Johnson LA; Rodansky ES; Haak AJ; Larsen SD; Neubig RR; Higgins PD
Inflamm Bowel Dis; 2014 Jan; 20(1):154-65. PubMed ID: 24280883
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.
Sisson TH; Ajayi IO; Subbotina N; Dodi AE; Rodansky ES; Chibucos LN; Kim KK; Keshamouni VG; White ES; Zhou Y; Higgins PD; Larsen SD; Neubig RR; Horowitz JC
Am J Pathol; 2015 Apr; 185(4):969-86. PubMed ID: 25681733
[TBL] [Abstract][Full Text] [Related]
4. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis.
Tagalakis AD; Madaan S; Larsen SD; Neubig RR; Khaw PT; Rodrigues I; Goyal S; Lim KS; Yu-Wai-Man C
J Nanobiotechnology; 2018 Nov; 16(1):97. PubMed ID: 30482196
[TBL] [Abstract][Full Text] [Related]
6. Prevention of bleomycin-induced lung fibrosis via inhibition of the MRTF/SRF transcription pathway.
Pawelec KM; Varnum M; Harkema JR; Auerbach B; Larsen SD; Neubig RR
Pharmacol Res Perspect; 2022 Dec; 10(6):e01028. PubMed ID: 36426895
[TBL] [Abstract][Full Text] [Related]
7. Redox modification of nuclear actin by MICAL-2 regulates SRF signaling.
Lundquist MR; Storaska AJ; Liu TC; Larsen SD; Evans T; Neubig RR; Jaffrey SR
Cell; 2014 Jan; 156(3):563-76. PubMed ID: 24440334
[TBL] [Abstract][Full Text] [Related]
8. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A.
Choi YJ; Koo JB; Kim HY; Seo JW; Lee EJ; Kim WR; Cho JY; Hahm KB; Hong SP; Kim DH; Yoo JH
Stem Cell Res Ther; 2019 Sep; 10(1):291. PubMed ID: 31547873
[TBL] [Abstract][Full Text] [Related]
9. Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.
Haak AJ; Tsou PS; Amin MA; Ruth JH; Campbell P; Fox DA; Khanna D; Larsen SD; Neubig RR
J Pharmacol Exp Ther; 2014 Jun; 349(3):480-6. PubMed ID: 24706986
[TBL] [Abstract][Full Text] [Related]
10. Cyclase-associated protein 2 (CAP2) controls MRTF-A localization and SRF activity in mouse embryonic fibroblasts.
Kepser LJ; Khudayberdiev S; Hinojosa LS; Macchi C; Ruscica M; Marcello E; Culmsee C; Grosse R; Rust MB
Sci Rep; 2021 Feb; 11(1):4789. PubMed ID: 33637797
[TBL] [Abstract][Full Text] [Related]
11. Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts.
Luchsinger LL; Patenaude CA; Smith BD; Layne MD
J Biol Chem; 2011 Dec; 286(51):44116-44125. PubMed ID: 22049076
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelial Cells by an MRTF-A Inhibitor.
Kobayashi M; Tokuda K; Kobayashi Y; Yamashiro C; Uchi SH; Hatano M; Kimura K
Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):528-537. PubMed ID: 30707754
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors.
Lockman K; Hinson JS; Medlin MD; Morris D; Taylor JM; Mack CP
J Biol Chem; 2004 Oct; 279(41):42422-30. PubMed ID: 15292266
[TBL] [Abstract][Full Text] [Related]
14. SRF/MRTF-A and liver cirrhosis: Pathologic associations.
Al-Hetty HRAK; Ismaeel GL; Mohammad WT; Toama MA; Kandeel M; Saleh MM; Turki Jalil A
J Dig Dis; 2022 Nov; 23(11):614-619. PubMed ID: 36601855
[TBL] [Abstract][Full Text] [Related]
15. Stereospecific Inhibitory Effects of CCG-1423 on the Cellular Events Mediated by Myocardin-Related Transcription Factor A.
Watanabe B; Minami S; Ishida H; Yoshioka R; Nakagawa Y; Morita T; Hayashi K
PLoS One; 2015; 10(8):e0136242. PubMed ID: 26295164
[TBL] [Abstract][Full Text] [Related]
16. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction.
Small EM; Thatcher JE; Sutherland LB; Kinoshita H; Gerard RD; Richardson JA; Dimaio JM; Sadek H; Kuwahara K; Olson EN
Circ Res; 2010 Jul; 107(2):294-304. PubMed ID: 20558820
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of Rho/MRTF/SRF Transcription Pathway Regulate Mitochondrial Function.
Patyal P; Zhang X; Verma A; Azhar G; Wei JY
Cells; 2024 Feb; 13(5):. PubMed ID: 38474356
[TBL] [Abstract][Full Text] [Related]
18. NG2/CSPG4, CD146/MCAM and VAP1/AOC3 are regulated by myocardin-related transcription factors in smooth muscle cells.
Rippe C; Morén B; Liu L; Stenkula KG; Mustaniemi J; Wennström M; Swärd K
Sci Rep; 2021 Mar; 11(1):5955. PubMed ID: 33727640
[TBL] [Abstract][Full Text] [Related]
19. Ablation of serum response factor in hepatic stellate cells attenuates liver fibrosis.
Kong M; Hong W; Shao Y; Lv F; Fan Z; Li P; Xu Y; Guo J
J Mol Med (Berl); 2019 Nov; 97(11):1521-1533. PubMed ID: 31435710
[TBL] [Abstract][Full Text] [Related]
20. SRF-MRTF signaling suppresses brown adipocyte development by modulating TGF-β/BMP pathway.
Liu R; Xiong X; Nam D; Yechoor V; Ma K
Mol Cell Endocrinol; 2020 Sep; 515():110920. PubMed ID: 32603734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
